Dolutegravir is a preferred medication for treating HIV infection, but it recently has been linked to a 6- to 9-fold increase in the risk for neural tube defects among babies born to mothers receiving ...
Dolutegravir is a preferred medication for treating HIV infection, but it recently has been linked to a 6- to 9-fold increase in the risk for neural tube defects among babies born to mothers receiving ...
View a listing of the Finnell Lab members and links to their bios. Research in the Finnell Laboratory focuses on genetic susceptibility to environmentally-induced complex congenital anomalies. To ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback